Psychedelic Stocks

We’ve been reporting on investment superstar Cathie Wood making the move into psychedelics. Her ARK Genomic Revolution ETF has begun buying into...

The Company is scheduled to begin production and analytical testing of MDMA this October in its recently completed EU-GMP pharmaceutical...

In southern B.C, there's a new 20,000 square foot production facility where one particular product is generating a lot of...

Phase III Trial to Cost approximately CA$3.75 million with Awakn's contribution expected to be approximately CA$1.25 million, Marks First Psychedelic...

The combination of psychedelics and psychotherapy is gaining increased acceptance and well-warranted research. But what about combining psychedelics and other...

Wesana Health May Sell Clinics to Focus Solely on Drug DevelopmentLeading this week’s psychedelic business news, Wesana Health (CSE: WESA;...

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) ("Silo Wellness" or the "Company"), a leading global psychedelics company, is...

Life Sciences is an investment category all its own. But it may be new to you, so if you want...

We’ve been getting mixed messaging from the Canadian federal government. On one hand, Health Canada has been recently denying special...

Imagine if Coloradans suffering from anxiety or post-traumatic stress disorder had a legal way to treat their ailments with psychedelic...